In Bartlett v. Mutual Pharmaceutical Co.,Inc., the United States Court of Appeals for the First Circuit held that generic drug manufacturers cannot rely on federal preemption to shield themselves from products liability claims alleging defective design of generic drugs. I. Facts Karen Bartlett (Bartlett) suffered burns on two-thirds of her body and permanent near-blindness several months […]